Science Explorer Back to mapMap
Discussion
Researcher · Arena Pharmaceuticals (United States) · United States

Daniel T. Connolly

Daniel T. Connolly publishes mostly in Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism, on topics such as Receptor Mechanisms and Signaling, Angiogenesis and VEGF in Cancer and Drug Transport and Resistance Mechanisms.

OpenAlex
World rank
#341,191
of 7,710,434 ranked researchers
Rank in United States
#122,691
of 1,627,098
Works
63
Citations
10k
Citations per work
162.4
h-index
37
i10-index 60Top 8.9% in Molecular Biology
Daniel T. Connolly

What does Daniel T. Connolly research?

Daniel T. Connolly's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (23%).

Everything else: 24 works · 38.7% of their workLife Sciences: 24 works · 38.1% of their workBiochemistry, Genetics and Molecular Biology: 24 works · 38.1% of their workMolecular Biology: 21 works · 33.3% of their workCancer Research: 3 works · 4.8% of their workHealth Sciences: 15 works · 23.2% of their workMedicine: 15 works · 23.2% of their workOncology: 5 works · 7.5% of their workEndocrinology, Diabetes and Metabolism: 4 works · 6.5% of their workSurgery: 3 works · 5.4% of their workHematology: 2 works · 3.8% of their workTHEIR WORKDaniel T.Connolly63works
Life Sciences38%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2438.7%
    1. Biochemistry, Genetics and Molecular Biology2438.1%
    1. Medicine1523.2%
  1. 1Molecular Biology33% of their works
  2. 2Oncology8% of their works
  3. 3Endocrinology, Diabetes and Metabolism6% of their works
  4. 4Surgery5% of their works
  5. 5Cancer Research5% of their works
  6. 6Hematology4% of their works

Research topics

Which keywords describe Daniel T. Connolly's research?

The keywords of their largest research topics: Crystal Structure, G-Protein-Coupled Receptors, endothelial progenitor cells, VEGF, ATP-dependent Transporters, Multidrug Resistance, Cardiovascular Outcomes and Type 2 Diabetes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Crystal Structure171 topic
  2. G-Protein-Coupled Receptors171 topic
  3. VEGF141 topic
  4. endothelial progenitor cells141 topic
  5. ATP-dependent Transporters101 topic
  6. Multidrug Resistance101 topic
  7. Cardiovascular Outcomes81 topic
  8. Type 2 Diabetes81 topic
  9. Cholesterol61 topic
  10. HIF-161 topic
  11. Metabolism61 topic
  12. Protease-Activated Receptors61 topic
  13. Thrombin61 topic
  14. Warburg Effect61 topic
  15. Glycans51 topic
  16. Glycosylation51 topic

Where does Daniel T. Connolly work?

Daniel T. Connolly's main affiliation in the publication record is Arena Pharmaceuticals (United States), United States.

How many publications and citations does Daniel T. Connolly have?

OpenAlex counts 63 works and 10,231 citations for Daniel T. Connolly, an h-index of 37, ranking #341,191 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Daniel T. Connolly. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.